Ascendis Pharma A/S Stock Forecast
Weaker technical forecast for Ascendis Pharma A/S as stock downgraded to Sell Candidate.
(Updated on Mar 27, 2024)
The Ascendis Pharma A/S stock price fell by -1.01% on the last day (Wednesday, 27th Mar 2024) from $149.96 to $148.44. During the last trading day the stock fluctuated 2.53% from a day low at $146.93 to a day high of $150.65. The price has fallen in 8 of the last 10 days and is down by -3.59% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -51 thousand shares and in total, 241 thousand shares were bought and sold for approximately $35.75 million.
The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $145.28 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 17.33% during the next 3 months and, with a 90% probability hold a price between $170.45 and $198.05 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ASND Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Ascendis Pharma A/S stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $148.93. On a fall, the stock will find some support from the short-term average at $146.24. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, February 23, 2024, and so far it has fallen -6.88%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Ascendis Pharma A/S stock
On the downside, the stock finds support just below today's level from accumulated volume at $139.29 and $132.40. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Ascendis Pharma A/S finds support just below today's level at $139.29. If this is broken, then the next support from accumulated volume will be at $132.40 and $129.93.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $3.72 (2.53%) between high and low. For the last week, the stock has had daily average volatility of 2.77%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ASND) For The Upcoming Trading Day Of Thursday 28th
For the upcoming trading day on Thursday, 28th we expect Ascendis Pharma A/S to open at $148.67, and during the day (based on 14 day Average True Range), to move between $143.71 and $153.17, which gives a possible trading interval of +/-$4.73 (+/-3.19%) up or down from last closing price. If Ascendis Pharma A/S takes out the full calculated possible swing range there will be an estimated 6.38% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $148.70 (0.18%) than the support at $139.29 (6.16%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Ascendis Pharma A/S stock A Buy?
Ascendis Pharma A/S holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -4.098 Sell Candidate Downgraded
Predicted Opening Price for Ascendis Pharma A/S of Thursday, March 28, 2024
Fair opening price March 28, 2024 | Current price |
---|---|
$148.67 ( 0.157%) | $148.44 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ASND
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 152.39 | 2.66 % | |
R2 | 150.97 | 1.71 % | ||
R1 | 150.09 | 1.11 % | ||
Current price: | 148.44 | |||
Support | S1 | 147.25 | -0.80 % | |
S2 | 146.37 | -1.39 % | ||
S3 | 144.95 | -2.35 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 156.39 | 5.36 % | |
R2 | 152.47 | 2.71 % | ||
R1 | 148.70 | 0.175 % | ||
Current price | 148.44 | |||
Support | S1 | 139.29 | -6.16% | |
S2 | 132.40 | -10.81% | ||
S3 | 129.93 | -12.47% |
FAQ
Click here for our free guide on how to buy Ascendis Pharma A/S Stock.